Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call
October 24, 2023 08:30 ET
|
Neuronetics
MALVERN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes
October 16, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility
October 03, 2023 09:21 ET
|
Neuronetics
MALVERN, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression
September 12, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
NeuroStar Advanced Therapy Wins 2023 dotCOMM Awards
August 21, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar® Platform
August 14, 2023 09:02 ET
|
Neuronetics
MALVERN, Pa., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of...
Neuronetics Reports Record Second Quarter 2023 Financial and Operating Results
August 08, 2023 07:30 ET
|
Neuronetics
MALVERN, Pa., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023 16:30 ET
|
Neuronetics
MALVERN, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
July 25, 2023 08:30 ET
|
Neuronetics
MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Expanded TMS Therapy Access Through Aetna® Health Plans
July 19, 2023 08:56 ET
|
Neuronetics
MALVERN, Pa., July 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...